| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.946 | 0.004 | 0.946 | Cyclophilin D inhibitor | 0.893 0.005 DBMET03319 0.91 0.005 DBMET03320 0.933 0.004 DBMET03321 0.945 0.004 DBMET03322 0.815 0.006 DBMET03323 | ||
| 0.833 | 0.005 | 0.843 | Antiobesity | 0.743 0.008 DBMET03319 0.809 0.005 DBMET03320 0.636 0.016 DBMET03321 0.843 0.005 DBMET03322 0.589 0.022 DBMET03323 | DBMET03322 | |
| 0.816 | 0.001 | 0.816 | Dipeptidyl peptidase inhibitor | 0.407 0.002 DBMET03319 0.091 0.011 DBMET03320 0.11 0.007 DBMET03321 0.339 0.002 DBMET03322 0.105 0.008 DBMET03323 | ||
| 0.813 | 0.001 | 0.813 | Dipeptidyl peptidase IV inhibitor | 0.437 0.002 DBMET03319 0.082 0.007 DBMET03320 0.098 0.005 DBMET03321 0.336 0.002 DBMET03322 0.08 0.008 DBMET03323 | ||
| 0.668 | 0.001 | 0.668 | Dipeptidyl peptidase VIII inhibitor | 0.125 0.003 DBMET03319 0.022 0.006 DBMET03320 0.147 0.003 DBMET03321 0.288 0.002 DBMET03322 0.017 0.009 DBMET03323 | ||
| 0.663 | 0.001 | 0.663 | Dipeptidyl peptidase IX inhibitor | 0.089 0.003 DBMET03319 0.017 0.01 DBMET03320 0.107 0.003 DBMET03321 0.186 0.002 DBMET03322 | ||
| 0.518 | 0.001 | 0.518 | Dipeptidyl peptidase II inhibitor | 0.153 0.003 DBMET03319 0.051 0.009 DBMET03320 0.049 0.01 DBMET03321 0.148 0.003 DBMET03322 0.062 0.007 DBMET03323 | ||
| 0.444 | 0.003 | 0.609 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.431 0.003 DBMET03319 0.609 0.002 DBMET03320 0.117 0.009 DBMET03321 0.417 0.003 DBMET03322 0.416 0.003 DBMET03323 | DBMET03320 | |
| 0.463 | 0.061 | 0.666 | Analgesic | 0.666 0.017 DBMET03319 0.619 0.024 DBMET03320 0.361 0.103 DBMET03322 0.48 0.055 DBMET03323 | DBMET03319 | |
| 0.314 | 0.075 | 0.513 | Immunostimulant | 0.401 0.049 DBMET03319 0.367 0.059 DBMET03320 0.513 0.027 DBMET03321 0.408 0.047 DBMET03322 0.459 0.035 DBMET03323 | DBMET03321 | |
| 0.224 | 0.055 | 0.263 | Sigma receptor agonist | 0.236 0.052 DBMET03319 0.2 0.062 DBMET03320 0.263 0.046 DBMET03322 0.214 0.057 DBMET03323 | DBMET03322 | |
| 0.256 | 0.092 | 0.256 | Ca(v)3.3 blocker | |||
| 0.135 | 0.004 | 0.135 | Prolyl endopeptidase inhibitor | 0.107 0.005 DBMET03319 0.078 0.012 DBMET03321 0.076 0.012 DBMET03322 | ||
| 0.219 | 0.096 | 0.583 | Hypoglycemic | 0.293 0.055 DBMET03319 0.312 0.049 DBMET03320 0.583 0.009 DBMET03321 0.404 0.027 DBMET03322 0.271 0.065 DBMET03323 | DBMET03321 | |
| 0.138 | 0.019 | 0.198 | Opioid kappa receptor antagonist | 0.198 0.01 DBMET03319 0.164 0.014 DBMET03320 0.108 0.029 DBMET03322 0.154 0.016 DBMET03323 | DBMET03319 | |
| 0.238 | 0.125 | 0.481 | Immunomodulator | 0.308 0.078 DBMET03319 0.321 0.071 DBMET03320 0.481 0.026 DBMET03321 0.353 0.059 DBMET03322 0.425 0.037 DBMET03323 | DBMET03321 | |
| 0.126 | 0.034 | 0.164 | Opioid antagonist | 0.164 0.022 DBMET03319 0.116 0.038 DBMET03320 0.091 0.055 DBMET03322 0.143 0.028 DBMET03323 | DBMET03319 | |
| 0.114 | 0.039 | 0.547 | NMDA receptor antagonist | 0.492 0.004 DBMET03319 0.547 0.004 DBMET03320 0.436 0.004 DBMET03323 | DBMET03320 | |
| 0.121 | 0.047 | 0.13 | Acetylcholine release stimulant | 0.127 0.038 DBMET03319 0.13 0.035 DBMET03320 0.119 0.05 DBMET03323 | DBMET03320 | |
| 0.098 | 0.025 | 0.098 | Ca(v)3.1 blocker | 0.088 0.04 DBMET03319 0.076 0.075 DBMET03320 0.082 0.053 DBMET03322 0.076 0.074 DBMET03323 | ||
| 0.121 | 0.05 | 0.463 | Expectorant | 0.263 0.011 DBMET03319 0.463 0.004 DBMET03320 0.272 0.01 DBMET03321 0.189 0.023 DBMET03322 0.356 0.006 DBMET03323 | DBMET03320 | |
| 0.1 | 0.032 | 0.136 | Opioid mu receptor antagonist | 0.136 0.021 DBMET03319 0.097 0.033 DBMET03320 0.061 0.053 DBMET03322 0.112 0.027 DBMET03323 | DBMET03319 | |
| 0.17 | 0.107 | 0.27 | Insulin sensitizer | 0.226 0.05 DBMET03319 0.27 0.024 DBMET03320 0.266 0.026 DBMET03323 | DBMET03320 | |
| 0.075 | 0.015 | 0.075 | Prolactin release inhibitor | 0.069 0.025 DBMET03319 0.061 0.046 DBMET03322 | ||
| 0.072 | 0.014 | 0.098 | Opioid kappa receptor agonist | 0.098 0.009 DBMET03319 0.053 0.022 DBMET03320 0.087 0.011 DBMET03322 0.041 0.032 DBMET03323 | DBMET03319 | |
| 0.091 | 0.032 | 0.155 | Opioid delta receptor antagonist | 0.155 0.019 DBMET03319 0.094 0.032 DBMET03320 0.055 0.05 DBMET03322 0.125 0.025 DBMET03323 | DBMET03319 | |
| 0.134 | 0.076 | 0.254 | Neurotrophic factor | 0.254 0.011 DBMET03319 0.117 0.1 DBMET03321 | DBMET03319 | |
| 0.084 | 0.032 | 0.112 | Glucagon-like peptide 1 agonist | 0.081 0.034 DBMET03319 0.094 0.025 DBMET03320 0.064 0.045 DBMET03322 0.112 0.016 DBMET03323 | DBMET03323 | |
| 0.08 | 0.035 | 0.096 | Cannabinoid receptor agonist | 0.096 0.027 DBMET03320 0.092 0.029 DBMET03323 | DBMET03320 | |
| 0.118 | 0.075 | 0.257 | Glutamate receptor antagonist | 0.231 0.019 DBMET03319 0.257 0.014 DBMET03320 0.134 0.063 DBMET03323 | DBMET03320 | |
| 0.154 | 0.112 | 0.358 | Psychostimulant | 0.313 0.039 DBMET03319 0.269 0.052 DBMET03320 0.155 0.112 DBMET03321 0.358 0.03 DBMET03323 | DBMET03323 | |
| 0.195 | 0.156 | 0.312 | Gastrin inhibitor | 0.312 0.026 DBMET03319 0.312 0.025 DBMET03320 0.185 0.172 DBMET03322 0.299 0.033 DBMET03323 | DBMET03320 | |
| 0.078 | 0.039 | 0.078 | Potassium channel (Tandem pore domain) blocker | |||
| 0.063 | 0.027 | 0.093 | Cannabinoid CB2 receptor antagonist | 0.093 0.017 DBMET03320 0.055 0.034 DBMET03323 | DBMET03320 | |
| 0.065 | 0.034 | 0.065 | Heme oxygenase stimulant | 0.059 0.05 DBMET03319 | ||
| 0.056 | 0.033 | 0.068 | Opioid agonist | 0.068 0.024 DBMET03319 0.051 0.038 DBMET03320 0.048 0.042 DBMET03322 0.054 0.035 DBMET03323 | DBMET03319 | |
| 0.052 | 0.033 | 0.056 | Sigma receptor antagonist | 0.044 0.038 DBMET03319 0.056 0.03 DBMET03320 | DBMET03320 | |
| 0.131 | 0.113 | 0.19 | Melanin inhibitor | 0.134 0.107 DBMET03319 0.19 0.045 DBMET03320 0.173 0.057 DBMET03321 0.135 0.106 DBMET03322 0.176 0.055 DBMET03323 | DBMET03320 | |
| 0.054 | 0.038 | 0.078 | Cannabinoid CB2 receptor agonist | 0.078 0.026 DBMET03320 | DBMET03320 | |
| 0.047 | 0.032 | 0.054 | Opioid mu receptor agonist | 0.051 0.028 DBMET03319 0.049 0.03 DBMET03320 0.054 0.026 DBMET03323 | DBMET03323 | |
| 0.053 | 0.042 | 0.098 | Bombesin 3 receptor antagonist | 0.072 0.023 DBMET03319 0.098 0.012 DBMET03320 0.072 0.023 DBMET03323 | DBMET03320 | |
| 0.051 | 0.041 | 0.054 | Acetylcholine M2 receptor agonist | 0.054 0.037 DBMET03319 | DBMET03319 | |
| 0.055 | 0.045 | 0.055 | Calcium channel T-type blocker | |||
| 0.07 | 0.062 | 0.097 | Analgesic, opioid | 0.097 0.033 DBMET03319 0.076 0.052 DBMET03320 0.079 0.049 DBMET03323 | DBMET03319 | |
| 0.065 | 0.061 | 0.267 | Epoxide hydrolase inhibitor | 0.09 0.032 DBMET03319 0.176 0.008 DBMET03320 0.267 0.005 DBMET03323 | DBMET03323 | |
| 0.015 | 0.013 | 0.018 | Antibiotic Tetracycline-like | 0.016 0.009 DBMET03319 0.018 0.005 DBMET03320 0.018 0.005 DBMET03321 0.016 0.01 DBMET03322 0.015 0.01 DBMET03323 | DBMET03321 | |
| 0.052 | 0.058 | 0.314 | NMDA 2C receptor antagonist | 0.133 0.009 DBMET03319 0.314 0.004 DBMET03320 0.158 0.006 DBMET03323 | DBMET03320 | |
| 0.01 | 0.017 | 0.012 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.009 DBMET03320 | DBMET03320 | |
| 0.016 | 0.025 | 0.022 | Somatostatin 3 agonist | 0.019 0.012 DBMET03319 0.022 0.008 DBMET03320 0.018 0.015 DBMET03323 | DBMET03320 | |
| 0.016 | 0.026 | 0.039 | Epoxide hydrolase 2 inhibitor | 0.036 0.011 DBMET03320 0.039 0.01 DBMET03323 | DBMET03323 | |
| 0.253 | 0.263 | 0.686 | Antiinflammatory | 0.311 0.205 DBMET03319 0.52 0.079 DBMET03320 0.686 0.034 DBMET03321 0.409 0.134 DBMET03322 0.393 0.143 DBMET03323 | DBMET03321 | |
| 0.04 | 0.059 | 0.069 | Cathepsin D inhibitor | 0.047 0.046 DBMET03319 0.057 0.036 DBMET03320 0.069 0.029 DBMET03323 | DBMET03323 | |
| 0.047 | 0.068 | 0.076 | Cathepsin E inhibitor | 0.076 0.025 DBMET03319 | DBMET03319 | |
| 0.016 | 0.038 | 0.08 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.024 0.023 DBMET03319 0.08 0.005 DBMET03320 | DBMET03320 | |
| 0.117 | 0.142 | 0.311 | Nitric oxide antagonist | 0.17 0.082 DBMET03320 0.311 0.038 DBMET03321 0.135 0.112 DBMET03322 0.142 0.102 DBMET03323 | DBMET03321 | |
| 0.063 | 0.089 | 0.082 | Vanilloid 4 agonist | 0.082 0.037 DBMET03323 | DBMET03323 | |
| 0.131 | 0.157 | 0.186 | Neurotensin receptor agonist | 0.155 0.09 DBMET03319 0.144 0.117 DBMET03320 0.186 0.044 DBMET03323 | DBMET03323 | |
| 0.015 | 0.044 | 0.048 | Protein 30S ribosomal subunit inhibitor | 0.048 0.008 DBMET03321 | DBMET03321 | |
| 0.021 | 0.051 | 0.049 | Epoxide hydrolase 1 inhibitor | 0.03 0.022 DBMET03319 0.041 0.011 DBMET03320 0.049 0.006 DBMET03323 | DBMET03323 | |
| 0.053 | 0.09 | 0.071 | Protein kinase B beta inhibitor | 0.071 0.056 DBMET03320 | DBMET03320 | |
| 0.107 | 0.145 | 0.424 | Growth hormone agonist | 0.125 0.113 DBMET03319 0.231 0.048 DBMET03320 0.424 0.013 DBMET03323 | DBMET03323 | |
| 0.056 | 0.095 | 0.09 | Acetylcholine nicotinic antagonist | 0.09 0.046 DBMET03319 | DBMET03319 | |
| 0.019 | 0.059 | 0.039 | Purinergic P2Y15 antagonist | 0.038 0.008 DBMET03320 0.027 0.025 DBMET03322 0.039 0.007 DBMET03323 | DBMET03323 | |
| 0.024 | 0.064 | 0.047 | Ceramide glucosyltransferase inhibitor | 0.047 0.009 DBMET03322 | DBMET03322 | |
| 0.04 | 0.09 | 0.112 | Angiotensin-converting enzyme inhibitor | 0.112 0.007 DBMET03319 | DBMET03319 | |
| 0.045 | 0.097 | 0.061 | Gonadotropin-releasing hormone receptor agonist | 0.061 0.038 DBMET03323 | DBMET03323 | |
| 0.01 | 0.061 | 0.062 | Cholecystokinin B antagonist | 0.033 0.019 DBMET03319 0.041 0.014 DBMET03320 0.062 0.008 DBMET03323 | DBMET03323 | |
| 0.034 | 0.089 | 0.052 | HCV NS3/NS4A protease inhibitor | 0.052 0.029 DBMET03319 0.049 0.033 DBMET03320 0.051 0.031 DBMET03323 | DBMET03319 | |
| 0.046 | 0.103 | 0.09 | Aminopeptidase I inhibitor | 0.076 0.046 DBMET03319 0.09 0.034 DBMET03320 0.086 0.037 DBMET03323 | DBMET03320 | |
| 0.025 | 0.085 | 0.037 | Neurokinin 2 agonist | 0.037 0.035 DBMET03323 | DBMET03323 | |
| 0.076 | 0.137 | 0.115 | Cholinergic antagonist | 0.115 0.079 DBMET03319 | DBMET03319 | |
| 0.075 | 0.137 | 0.11 | Acetylcholine antagonist | 0.11 0.079 DBMET03319 | DBMET03319 | |
| 0.013 | 0.075 | 0.102 | Cholecystokinin antagonist | 0.052 0.024 DBMET03319 0.064 0.017 DBMET03320 0.102 0.008 DBMET03323 | DBMET03323 | |
| 0.019 | 0.084 | 0.032 | Caspase 6 inhibitor | 0.032 0.018 DBMET03323 | DBMET03323 | |
| 0.02 | 0.09 | 0.229 | NMDA 2A receptor antagonist | 0.115 0.01 DBMET03319 0.229 0.004 DBMET03320 0.151 0.007 DBMET03323 | DBMET03320 | |
| 0.011 | 0.082 | 0.027 | Lysine carboxypeptidase inhibitor | 0.027 0.019 DBMET03319 | DBMET03319 | |
| 0.008 | 0.083 | 0.049 | Squalene synthetase inhibitor | 0.049 0.015 DBMET03320 0.037 0.019 DBMET03323 | DBMET03320 | |
| 0.031 | 0.107 | 0.084 | Alpha-mannosidase inhibitor | 0.084 0.01 DBMET03320 0.064 0.022 DBMET03321 0.067 0.019 DBMET03322 0.058 0.03 DBMET03323 | DBMET03320 | |
| 0.007 | 0.086 | 0.017 | Angiotensin-converting enzyme 2 inhibitor | 0.017 0.013 DBMET03319 | DBMET03319 | |
| 0.049 | 0.128 | 0.102 | Myeloperoxidase inhibitor | 0.102 0.033 DBMET03320 0.086 0.055 DBMET03323 | DBMET03320 | |
| 0.008 | 0.088 | 0.051 | Arginase inhibitor | 0.047 0.017 DBMET03319 0.051 0.014 DBMET03320 0.032 0.029 DBMET03321 0.047 0.017 DBMET03323 | DBMET03320 | |
| 0.066 | 0.154 | 0.148 | AMP-activated protein kinase stimulant | 0.096 0.076 DBMET03320 0.148 0.03 DBMET03321 | DBMET03321 | |
| 0.085 | 0.174 | 0.128 | Acetylcholine M1 receptor antagonist | 0.128 0.098 DBMET03319 | DBMET03319 | |
| 0.018 | 0.109 | 0.047 | Carboxypeptidase B inhibitor | 0.041 0.012 DBMET03320 0.047 0.008 DBMET03323 | DBMET03323 | |
| 0.033 | 0.134 | 0.067 | CD45 antagonist | 0.067 0.017 DBMET03319 0.046 0.044 DBMET03320 0.062 0.02 DBMET03323 | DBMET03319 | |
| 0.023 | 0.125 | 0.08 | Protein 50S ribosomal subunit inhibitor | 0.08 0.019 DBMET03321 | DBMET03321 | |
| 0.132 | 0.252 | 0.332 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET03319 0.319 0.019 DBMET03320 0.332 0.015 DBMET03321 0.188 0.116 DBMET03322 0.326 0.017 DBMET03323 | DBMET03321 | |
| 0.059 | 0.179 | 0.104 | Vanilloid agonist | 0.085 0.056 DBMET03320 0.104 0.029 DBMET03323 | DBMET03323 | |
| 0.009 | 0.129 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.017 DBMET03321 | DBMET03321 | |
| 0.017 | 0.145 | 0.066 | Mannosidase inhibitor | 0.066 0.013 DBMET03320 0.048 0.028 DBMET03321 0.049 0.027 DBMET03322 0.046 0.03 DBMET03323 | DBMET03320 | |
| 0.017 | 0.152 | 0.042 | Cholecystokinin B agonist | 0.042 0.021 DBMET03323 | DBMET03323 | |
| 0.005 | 0.146 | 0.078 | Cholecystokinin A antagonist | 0.078 0.013 DBMET03323 | DBMET03323 | |
| 0.019 | 0.161 | 0.203 | NMDA 2 receptor antagonist | 0.103 0.03 DBMET03319 0.203 0.009 DBMET03320 0.109 0.028 DBMET03323 | DBMET03320 | |
| 0.088 | 0.236 | 0.381 | Hypolipemic | 0.167 0.121 DBMET03319 0.381 0.029 DBMET03320 0.281 0.055 DBMET03321 0.269 0.06 DBMET03323 | DBMET03320 | |
| 0.136 | 0.288 | 0.307 | Insulysin inhibitor | 0.198 0.16 DBMET03319 0.209 0.144 DBMET03320 0.307 0.055 DBMET03323 | DBMET03323 | |
| 0.046 | 0.203 | 0.345 | GABA C receptor agonist | 0.101 0.065 DBMET03319 0.345 0.007 DBMET03320 0.294 0.01 DBMET03323 | DBMET03320 | |
| 0.07 | 0.232 | 0.201 | Diuretic | 0.198 0.045 DBMET03319 0.201 0.044 DBMET03320 0.119 0.106 DBMET03321 0.168 0.063 DBMET03323 | DBMET03320 | |
| 0.036 | 0.2 | 0.064 | Caspase 9 inhibitor | 0.064 0.039 DBMET03323 | DBMET03323 | |
| 0.029 | 0.198 | 0.083 | Glucosylceramidase inhibitor | 0.083 0.014 DBMET03322 | DBMET03322 | |
| 0.108 | 0.279 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.163 0.019 DBMET03320 0.14 0.074 DBMET03323 | DBMET03320 | |
| 0.016 | 0.187 | 0.043 | Glutamate (mGluR3) agonist | 0.031 0.027 DBMET03319 0.043 0.008 DBMET03320 0.034 0.019 DBMET03323 | DBMET03320 | |
| 0.136 | 0.309 | 0.398 | Apoptosis antagonist | 0.248 0.129 DBMET03319 0.29 0.092 DBMET03320 0.314 0.076 DBMET03321 0.398 0.039 DBMET03323 | DBMET03323 | |
| 0.135 | 0.308 | 0.289 | Tyrosine 3 hydroxylase inhibitor | 0.289 0.039 DBMET03320 0.256 0.063 DBMET03323 | DBMET03320 | |
| 0.007 | 0.18 | 0.017 | 5-Alpha-reductase 2 inhibitor | 0.017 0.016 DBMET03320 | DBMET03320 | |
| 0.012 | 0.191 | 0.039 | GABA uptake inhibitor | 0.039 0.028 DBMET03320 | DBMET03320 | |
| 0.028 | 0.207 | 0.161 | Topoisomerase II alpha inhibitor | 0.161 0.021 DBMET03320 0.076 0.056 DBMET03321 0.077 0.055 DBMET03323 | DBMET03320 | |
| 0.008 | 0.19 | 0.024 | Caspase 8 inhibitor | 0.024 0.008 DBMET03323 | DBMET03323 | |
| 0.012 | 0.196 | 0.064 | Glutamate (mGluR1) antagonist | 0.064 0.035 DBMET03320 | DBMET03320 | |
| 0.033 | 0.218 | 0.124 | Glycine receptor antagonist | 0.124 0.016 DBMET03320 0.114 0.022 DBMET03323 | DBMET03320 | |
| 0.051 | 0.239 | 0.296 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.089 DBMET03319 0.296 0.017 DBMET03320 0.16 0.05 DBMET03323 | DBMET03320 | |
| 0.037 | 0.226 | 0.12 | Glycine receptor agonist | 0.12 0.013 DBMET03320 | DBMET03320 | |
| 0.077 | 0.274 | 0.185 | Adenylate cyclase stimulant | 0.174 0.031 DBMET03320 0.185 0.022 DBMET03323 | DBMET03323 | |
| 0.008 | 0.218 | 0.051 | Ribonucleoside-diphosphate reductase inhibitor | 0.051 0.04 DBMET03323 | DBMET03323 | |
| 0.023 | 0.233 | 0.066 | Factor IXa inhibitor | 0.066 0.023 DBMET03321 | DBMET03321 | |
| 0.036 | 0.247 | 0.056 | Lipocortins synthesis agonist | 0.056 0.046 DBMET03321 | DBMET03321 | |
| 0.017 | 0.229 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET03321 | DBMET03321 | |
| 0.021 | 0.234 | 0.091 | Na+ K+ transporting ATPase inhibitor | 0.091 0.04 DBMET03320 | DBMET03320 | |
| 0.007 | 0.225 | 0.053 | Ribonucleotide reductase inhibitor | 0.053 0.04 DBMET03323 | DBMET03323 | |
| 0.038 | 0.261 | 0.133 | Anabolic | 0.133 0.029 DBMET03320 0.101 0.061 DBMET03323 | DBMET03320 | |
| 0.018 | 0.242 | 0.062 | Glutamate (mGluR8) antagonist | 0.062 0.005 DBMET03319 0.037 0.022 DBMET03320 | DBMET03319 | |
| 0.013 | 0.238 | 0.153 | Antineoplastic antibiotic | 0.153 0.03 DBMET03321 | DBMET03321 | |
| 0.13 | 0.358 | 0.349 | Interleukin 2 agonist | 0.267 0.1 DBMET03319 0.209 0.175 DBMET03320 0.349 0.046 DBMET03321 0.311 0.066 DBMET03323 | DBMET03321 | |
| 0.031 | 0.26 | 0.117 | Aminopeptidase B inhibitor | 0.102 0.064 DBMET03319 0.117 0.054 DBMET03320 0.117 0.054 DBMET03323 | DBMET03323 | |
| 0.069 | 0.298 | 0.19 | Antiamyloidogenic | 0.187 0.109 DBMET03319 0.19 0.107 DBMET03323 | DBMET03323 | |
| 0.081 | 0.313 | 0.143 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.108 DBMET03319 0.143 0.073 DBMET03320 | DBMET03320 | |
| 0.105 | 0.34 | 0.224 | Nootropic | 0.199 0.159 DBMET03320 0.224 0.131 DBMET03322 | DBMET03322 | |
| 0.015 | 0.254 | 0.104 | Carbamoyl phosphate synthetase inhibitor | 0.104 0.019 DBMET03320 0.081 0.028 DBMET03323 | DBMET03320 | |
| 0.03 | 0.269 | 0.145 | Glutamate dehydrogenase inhibitor | 0.145 0.017 DBMET03320 0.116 0.024 DBMET03323 | DBMET03320 | |
| 0.001 | 0.243 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.009 DBMET03320 | DBMET03320 | |
| 0.007 | 0.256 | 0.065 | NMDA receptor subunit 3A antagonist | 0.065 0.015 DBMET03320 | DBMET03320 | |
| 0.005 | 0.264 | 0.038 | 5-Alpha-reductase inhibitor | 0.038 0.025 DBMET03320 | DBMET03320 | |
| 0.011 | 0.27 | 0.052 | NMDA receptor subunit 3B antagonist | 0.052 0.023 DBMET03320 | DBMET03320 | |
| 0.06 | 0.325 | 0.195 | Spasmolytic | 0.195 0.124 DBMET03319 0.181 0.136 DBMET03321 | DBMET03319 | |
| 0.083 | 0.352 | 0.261 | Superoxide dismutase inhibitor | 0.261 0.068 DBMET03320 | DBMET03320 | |
| 0.045 | 0.315 | 0.176 | Amyloid beta aggregation inhibitor | 0.176 0.091 DBMET03323 | DBMET03323 | |
| 0.011 | 0.282 | 0.049 | Membrane dipeptidase inhibitor | 0.044 0.021 DBMET03320 0.049 0.016 DBMET03323 | DBMET03323 | |
| 0.061 | 0.334 | 0.129 | Sphingosine 1-phosphate receptor 2 antagonist | 0.119 0.099 DBMET03320 0.129 0.076 DBMET03323 | DBMET03323 | |
| 0.059 | 0.335 | 0.148 | Factor V inhibitor | 0.148 0.019 DBMET03323 | DBMET03323 | |
| 0.017 | 0.295 | 0.042 | Kainate receptor agonist | 0.042 0.026 DBMET03320 | DBMET03320 | |
| 0.084 | 0.368 | 0.348 | Immunosuppressant | 0.348 0.088 DBMET03321 0.239 0.158 DBMET03322 0.253 0.145 DBMET03323 | DBMET03321 | |
| 0.076 | 0.365 | 0.224 | Lipocortins synthesis antagonist | 0.224 0.043 DBMET03320 0.2 0.056 DBMET03323 | DBMET03320 | |
| 0.031 | 0.322 | 0.093 | Glutamate (mGluR6) antagonist | 0.093 0.014 DBMET03320 0.069 0.041 DBMET03323 | DBMET03320 | |
| 0.066 | 0.362 | 0.135 | Interferon gamma antagonist | 0.13 0.11 DBMET03320 0.135 0.101 DBMET03322 0.129 0.114 DBMET03323 | DBMET03322 | |
| 0.007 | 0.312 | 0.066 | Ornithine carbamoyltransferase inhibitor | 0.066 0.028 DBMET03320 0.051 0.039 DBMET03323 | DBMET03320 | |
| 0.035 | 0.345 | 0.112 | Proteasome inhibitor | 0.112 0.072 DBMET03323 | DBMET03323 | |
| 0.028 | 0.347 | 0.135 | GABA C receptor antagonist | 0.135 0.04 DBMET03320 | DBMET03320 | |
| 0.035 | 0.355 | 0.107 | Microtubule formation inhibitor | 0.107 0.078 DBMET03320 | DBMET03320 | |
| 0.062 | 0.384 | 0.153 | Vanilloid 1 agonist | 0.132 0.063 DBMET03320 0.153 0.035 DBMET03323 | DBMET03323 | |
| 0.04 | 0.367 | 0.088 | Transcription factor NF kappa B stimulant | 0.088 0.054 DBMET03321 0.084 0.061 DBMET03323 | DBMET03321 | |
| 0.025 | 0.356 | 0.146 | Mucolytic | 0.146 0.035 DBMET03320 0.118 0.056 DBMET03323 | DBMET03320 | |
| 0.058 | 0.39 | 0.127 | Pregnane X receptor agonist | 0.127 0.107 DBMET03320 | DBMET03320 | |
| 0.023 | 0.361 | 0.102 | Ornithine decarboxylase inhibitor | 0.102 0.042 DBMET03320 0.089 0.057 DBMET03323 | DBMET03320 | |
| 0.048 | 0.386 | 0.355 | Free radical scavenger | 0.355 0.038 DBMET03321 0.166 0.128 DBMET03323 | DBMET03321 | |
| 0.016 | 0.355 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 DBMET03320 0.044 0.041 DBMET03323 | DBMET03320 | |
| 0.061 | 0.413 | 0.257 | Neurotrophic factor enhancer | 0.257 0.035 DBMET03320 0.153 0.134 DBMET03323 | DBMET03320 | |
| 0.009 | 0.362 | 0.116 | Phosphofructokinase-1 inhibitor | 0.113 0.027 DBMET03320 0.116 0.026 DBMET03323 | DBMET03323 | |
| 0.031 | 0.388 | 0.149 | Bone formation stimulant | 0.111 0.094 DBMET03320 0.149 0.06 DBMET03323 | DBMET03323 | |
| 0.014 | 0.389 | 0.066 | Carbonic anhydrase stimulant | 0.066 0.035 DBMET03323 | DBMET03323 | |
| 0.034 | 0.409 | 0.417 | Angiogenesis stimulant | 0.417 0.019 DBMET03321 0.303 0.048 DBMET03323 | DBMET03321 | |
| 0.056 | 0.434 | 0.168 | Phospholipase C inhibitor | 0.168 0.075 DBMET03320 0.163 0.083 DBMET03323 | DBMET03320 | |
| 0.035 | 0.422 | 0.182 | Anticonvulsant | 0.159 0.118 DBMET03320 0.182 0.097 DBMET03323 | DBMET03323 | |
| 0.056 | 0.445 | 0.233 | DNA synthesis inhibitor | 0.233 0.08 DBMET03320 0.175 0.162 DBMET03321 0.199 0.124 DBMET03323 | DBMET03320 | |
| 0.012 | 0.406 | 0.04 | Glutamate (mGluR8) agonist | 0.04 0.022 DBMET03320 | DBMET03320 | |
| 0.084 | 0.479 | 0.126 | CC chemokine 6 receptor antagonist | 0.126 0.088 DBMET03321 | DBMET03321 | |
| 0.006 | 0.407 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.031 DBMET03320 | DBMET03320 | |
| 0.004 | 0.405 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET03320 | DBMET03320 | |
| 0.008 | 0.415 | 0.062 | Argininosuccinate synthase inhibitor | 0.062 0.035 DBMET03320 0.05 0.047 DBMET03323 | DBMET03320 | |
| 0.006 | 0.415 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET03323 | DBMET03323 | |
| 0.023 | 0.434 | 0.078 | Keratolytic | 0.078 0.052 DBMET03320 | DBMET03320 | |
| 0.023 | 0.44 | 0.098 | Caspase 3 inhibitor | 0.098 0.096 DBMET03323 | DBMET03323 | |
| 0.059 | 0.477 | 0.322 | Antithrombotic | 0.195 0.184 DBMET03319 0.224 0.15 DBMET03320 0.322 0.076 DBMET03321 0.251 0.126 DBMET03323 | DBMET03321 | |
| 0.029 | 0.447 | 0.123 | Anticoagulant | 0.123 0.108 DBMET03321 | DBMET03321 | |
| 0.01 | 0.432 | 0.092 | Glutamate decarboxylase inhibitor | 0.092 0.034 DBMET03320 0.075 0.049 DBMET03323 | DBMET03320 | |
| 0.101 | 0.529 | 0.228 | 5 Hydroxytryptamine uptake stimulant | 0.228 0.106 DBMET03320 0.204 0.144 DBMET03323 | DBMET03320 | |
| 0.047 | 0.476 | 0.269 | Hepatoprotectant | 0.269 0.038 DBMET03321 | DBMET03321 | |
| 0.021 | 0.453 | 0.159 | Anesthetic general | 0.157 0.106 DBMET03320 0.159 0.104 DBMET03323 | DBMET03323 | |
| 0.028 | 0.461 | 0.099 | NADH dehydrogenase inhibitor | 0.099 0.045 DBMET03320 | DBMET03320 | |
| 0.025 | 0.463 | 0.096 | Triose-phosphate isomerase inhibitor | 0.092 0.057 DBMET03320 0.096 0.052 DBMET03323 | DBMET03323 | |
| 0.039 | 0.477 | 0.373 | Antioxidant | 0.373 0.04 DBMET03321 0.167 0.145 DBMET03323 | DBMET03321 | |
| 0.006 | 0.453 | 0.042 | Toll-Like receptor 2 agonist | 0.042 0.028 DBMET03323 | DBMET03323 | |
| 0.037 | 0.485 | 0.292 | Vasodilator | 0.292 0.051 DBMET03321 | DBMET03321 | |
| 0.019 | 0.471 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | 0.099 0.059 DBMET03323 | DBMET03323 | |
| 0.014 | 0.468 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.056 0.044 DBMET03323 | DBMET03323 | |
| 0.011 | 0.486 | 0.056 | NMDA receptor agonist | 0.056 0.054 DBMET03323 | DBMET03323 | |
| 0.036 | 0.513 | 0.085 | Hematopoietic | 0.085 0.061 DBMET03323 | DBMET03323 | |
| 0.022 | 0.5 | 0.109 | HIV-1 integrase (Overall Integration) inhibitor | 0.109 0.047 DBMET03320 | DBMET03320 | |
| 0.009 | 0.499 | 0.075 | Histidine decarboxylase inhibitor | 0.075 0.046 DBMET03320 | DBMET03320 | |
| 0.049 | 0.544 | 0.173 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.173 0.103 DBMET03320 | DBMET03320 | |
| 0.008 | 0.505 | 0.076 | Phenylalanine 4-hydroxylase inhibitor | 0.076 0.04 DBMET03320 | DBMET03320 | |
| 0.023 | 0.525 | 0.182 | Arachidonic acid antagonist | 0.182 0.051 DBMET03320 0.126 0.118 DBMET03323 | DBMET03320 | |
| 0.008 | 0.516 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.031 DBMET03320 | DBMET03320 | |
| 0.022 | 0.55 | 0.083 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.083 0.076 DBMET03320 | DBMET03320 | |
| 0.028 | 0.558 | 0.124 | Hemostatic | 0.124 0.106 DBMET03321 | DBMET03321 | |
| 0.037 | 0.574 | 0.085 | Glutamate release inhibitor | 0.085 0.076 DBMET03323 | DBMET03323 | |
| 0.031 | 0.583 | 0.124 | Adenylate kinase inhibitor | 0.124 0.041 DBMET03320 0.109 0.055 DBMET03323 | DBMET03320 | |
| 0.024 | 0.579 | 0.1 | DNA polymerase I inhibitor | 0.1 0.086 DBMET03323 | DBMET03323 | |
| 0.007 | 0.564 | 0.082 | Porphobilinogen synthase inhibitor | 0.082 0.046 DBMET03320 | DBMET03320 | |
| 0.011 | 0.579 | 0.085 | Prostaglandin F2 alpha antagonist | 0.085 0.019 DBMET03323 | DBMET03323 | |
| 0.025 | 0.601 | 0.141 | Peroxidase inhibitor | 0.141 0.083 DBMET03320 | DBMET03320 | |
| 0.023 | 0.601 | 0.175 | Succinate dehydrogenase inhibitor | 0.175 0.074 DBMET03320 0.159 0.096 DBMET03323 | DBMET03320 | |
| 0.009 | 0.599 | 0.081 | GABA aminotransferase inhibitor | 0.081 0.046 DBMET03323 | DBMET03323 | |
| 0.05 | 0.643 | 0.395 | Sodium/bile acid cotransporter inhibitor | 0.395 0.019 DBMET03320 0.359 0.035 DBMET03323 | DBMET03320 | |
| 0.005 | 0.611 | 0.067 | Catalase inhibitor | 0.067 0.057 DBMET03323 | DBMET03323 | |
| 0.012 | 0.621 | 0.075 | GABA B receptor agonist | 0.073 0.06 DBMET03320 0.075 0.055 DBMET03323 | DBMET03323 | |
| 0.031 | 0.653 | 0.338 | Cholesterol antagonist | 0.338 0.07 DBMET03320 0.242 0.131 DBMET03323 | DBMET03320 | |
| 0.011 | 0.638 | 0.095 | Ferrochelatase inhibitor | 0.095 0.077 DBMET03320 | DBMET03320 | |
| 0.023 | 0.662 | 0.168 | Platelet adhesion inhibitor | 0.168 0.089 DBMET03321 | DBMET03321 | |
| 0.013 | 0.653 | 0.165 | Thrombolytic | 0.156 0.077 DBMET03321 0.165 0.071 DBMET03323 | DBMET03323 | |
| 0.013 | 0.655 | 0.038 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.031 DBMET03323 | DBMET03323 | |
| 0.012 | 0.66 | 0.121 | Chelator | 0.121 0.052 DBMET03320 0.103 0.073 DBMET03323 | DBMET03320 | |
| 0.018 | 0.675 | 0.219 | Insulin secretagoues | 0.219 0.028 DBMET03321 | DBMET03321 | |
| 0.016 | 0.685 | 0.102 | Aldehyde dehydrogenase inhibitor | 0.102 0.095 DBMET03320 | DBMET03320 | |
| 0.02 | 0.714 | 0.412 | Antibacterial | 0.412 0.071 DBMET03321 | DBMET03321 | |
| 0.004 | 0.703 | 0.015 | Integrin beta6 antagonist | 0.015 0.008 DBMET03323 | DBMET03323 | |
| 0.002 | 0.705 | 0.05 | Thromboxane A2 antagonist | 0.05 0.036 DBMET03323 | DBMET03323 | |
| 0.011 | 0.714 | 0.13 | Toll-Like receptor 2 antagonist | 0.13 0.068 DBMET03323 | DBMET03323 | |
| 0.004 | 0.72 | 0.037 | Protocollagen prolyl hydroxylase inhibitor | 0.037 0.009 DBMET03320 | DBMET03320 | |
| 0.033 | 0.765 | 0.274 | 5 Hydroxytryptamine release inhibitor | 0.274 0.196 DBMET03320 | DBMET03320 | |
| 0.003 | 0.736 | 0.047 | Thromboxane antagonist | 0.047 0.044 DBMET03323 | DBMET03323 | |
| 0.004 | 0.766 | 0.055 | Thromboxane synthase inhibitor | 0.055 0.036 DBMET03323 | DBMET03323 | |
| 0.022 | 0.786 | 0.273 | Apoptosis agonist | 0.273 0.193 DBMET03321 | DBMET03321 | |
| 0.005 | 0.814 | 0.338 | Platelet antagonist | 0.153 0.141 DBMET03320 0.338 0.041 DBMET03323 | DBMET03323 | |
| 0.026 | 0.838 | 0.109 | Folate antagonist | 0.109 0.051 DBMET03323 | DBMET03323 | |
| 0.005 | 0.861 | 0.201 | Interleukin antagonist | 0.201 0.083 DBMET03323 | DBMET03323 | |
| 0.015 | 0.885 | 0.136 | Interleukin 4 antagonist | 0.136 0.065 DBMET03322 | DBMET03322 | |
| 0.003 | 0.88 | 0.175 | Selectin antagonist | 0.175 0.014 DBMET03321 | DBMET03321 | |
| 0.009 | 0.899 | 0.102 | CDK3/cyclin E inhibitor | 0.102 0.083 DBMET03323 | DBMET03323 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |